Feasibility of switching anti-tumour necrosis factor-alpha therapy in patients with rheumatois arthritis

被引：0
|
作者：
Walsh, C. A. E. [1 ]
Minnock, P. [1 ]
Slattery, C. [1 ]
Kennedy, N. [1 ]
Veale, D. J. [1 ]
Bresnihan, B. [1 ]
FitzGerald, O. [1 ]
机构：
[1] St Vincents Univ Hosp, Dept Rheumatol, Dublin, Ireland
来源：
RHEUMATOLOGY | 2006年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I52 / I52
页数：1
相关论文
共 50 条
  • [21] Exacerbation of psoriatic skin lesions in patients with psoriatic arthritis receiving anti-tumour necrosis factor-alpha therapy: description of 3 cases and review of the literature
    Mourao, A. F.
    Rustin, M.
    Isenberg, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (03) : 408 - 410
  • [22] SERUM AMYLOID A PROTEIN IN SPONDYLOARTHRITIS PATIENTS UNDER ANTI-TUMOUR NECROSIS FACTOR-ALPHA: AN USEFUL BIOMARKER?
    Aguiar, F.
    Martins-Rocha, T.
    Rosa-Goncalves, D.
    Fonseca, R.
    Brito, I.
    Bernardo, A.
    Bernardes, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 585 - 585
  • [23] Relative risk of tuberculosis in patients with rheumatic diseases managed with anti-tumour necrosis factor-alpha therapy: A nationwide cohort study
    Aydin, Volkan
    Akici, Ahmet
    Isli, Fatma
    Aksoy, Mesil
    Aydin, Mehtap
    Gursoz, Hakki
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, 44 (04) : 553 - 560
  • [24] AUTOANTIBODIES AND SYSTEMIC LUPUS ERYTHEMATOSUS INDUCED BY ANTI-TUMOUR NECROSIS FACTOR ALPHA THERAPY IN RHEUMATOID ARTHRITIS
    Oliveira, D. Santos
    Martins, A.
    Martins, F. R.
    Pinheiro, F. Oliveira
    Rato, M.
    Fonseca, D.
    Fernandes, B. M.
    Garcia, S.
    Vaz, C.
    Bernardes, M.
    Costa, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 318 - 318
  • [25] Immunogenicity of anti-tumour necrosis factor therapy in Korean patients with rheumatoid arthritis and ankylosing spondylitis
    Jung, Seung Min
    Kim, Hyun-Sook
    Kim, Hae-Rim
    Kim, Na Young
    Lee, Jung-Hwa
    Kim, Juryun
    Kwok, Seung-Ki
    Park, Kyung-Su
    Park, Sung-Hwan
    Kim, Ho-Youn
    Ju, Ji Hyeon
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2014, 21 (01) : 20 - 25
  • [26] Expansion of T cells expressing inhibitory natural killer receptors in patients with rheumatoid arthritis in clinical remission following anti-tumour necrosis factor-alpha therapy
    Walsh, C. A. E.
    O'Farrelly, C.
    Golden-Mason, L.
    Veale, D. J.
    FitzGerald, O.
    Bresnihan, B.
    Fearon, U.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 468 - 468
  • [27] DRUG SURVIVAL OF SECOND BIOLOGIC DMARD THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS: COMPARISON OF A SECOND ANTI-TUMOUR NECROSIS FACTOR WITH A SECOND NON-ANTI-TUMOUR NECROSIS FACTOR AFTER DISCONTINUATION OF A FIRST ANTI-TUMOUR NECROSIS FACTOR
    Wilke, Thomas
    Mueller, Sabrina
    Majer, Istvan
    Heisen, Marieke
    Fuchs, Andreas
    Maywald, Ulf
    RHEUMATOLOGY, 2016, 55 : 105 - 105
  • [28] Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis
    Feldmann, M
    Elliott, MJ
    Woody, JN
    Maini, RN
    ADVANCES IN IMMUNOLOGY, VOL 64, 1997, 64 : 283 - 350
  • [29] Digital vasculitis: a late complication of anti-tumour necrosis factor alpha therapy
    Mangat, Pamela
    Whittle, Samuel
    Cleland, Les
    Limaye, Vidya
    CLINICAL RHEUMATOLOGY, 2008, 27 (12) : 1593 - 1595
  • [30] Digital vasculitis: a late complication of anti-tumour necrosis factor alpha therapy
    Pamela Mangat
    Samuel Whittle
    Les Cleland
    Vidya Limaye
    Clinical Rheumatology, 2008, 27 : 1593 - 1595
12345